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Abstract
The physiology of tendons and the continuous strains experienced daily make
tendons very prone to injury. Excessive and prolonged loading forces and aging
also contribute to the onset and progression of tendon injuries, and conventional
treatments have limited efficacy in restoring tendon biomechanics. Tissue engi-
neering and regenerative medicine (TERM) approaches hold the promise to
provide therapeutic solutions for injured or damaged tendons despite the chal-
lenging cues of tendon niche and the lack of tendon-specific factors to guide
cellular responses and tackle regeneration. The roots of engineering tendon sub-
stitutes lay in multifactorial approaches from adequate stem cells sources and
environmental stimuli to the construction of multiscale 3D scaffolding systems.
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To achieve such advanced tendon substitutes, incremental strategies have been
pursued to more closely recreate the native tendon requirements providing struc-
tural as well as physical and chemical cues combined with biochemical and
mechanical stimuli to instruct cell behavior in 3D architectures, pursuing mechan-
ically competent constructs with adequate maturation before implantation.
1 Introduction
Tendon is composed mainly of water (70% of dry weight) and a solid matrix (30% of
dry weight) (Sharma and Maffulli 2005) mostly of collagen (70–80%), which is the
force-transmitting unit of tendon (Magnusson et al. 2003; de Aro et al. 2012).
Collagen type I is the main type of collagen within tendons (95% of total collagen
and 60–85% of matrix dry weight (Screen et al. 2015)) followed by collagen type III
and collagen type V. The alignment of collagen type I is recognized as the principal
structural feature of healthy tendons (Lipman et al. 2018). Together with collagen
type I, type V, and type XI, collagen type III is a fibril-forming collagen and widely
distributed in collagen I containing tissues. Upon injury, collagen type III increases.
This has been associated to its rapid cross-linking contributing to stabilize the repair
site and to the remodeling process of the matrix highlighting the importance of
collagen type III in tendon healing processes. However, collagen type III forms
smaller and less organized fibrils than the ones of collagen type I. Abundant collagen
type III results in a tendon with inferior mechanical properties, which has been
related to a degenerative process (Millar et al. 2015). Collagen type V is important
for regulation and stabilization of collagen type I structures during self-assembly
(Wenstrup et al. 2004), while collagen type VI regulates collagen I fibrillogenesis to
form a functional and mature tendon (Izu et al. 2011).
Tendons are mainly composed of tenoblasts and tenocytes approximately 90–
95% of tendon cells (Schneider et al. 2017) whose major function relies in the
synthesis and maintenance of the tendon extracellular matrix. Tenoblasts are roundly
shaped cells with a large, ovoid nucleus that mature to spindle-shaped tenocytes with
elongated nuclei in response to mechanical regulators and to growth factors during
tendon development. These cells are discriminated based on morphology; however,
precise identification based on specific markers is still lacking. Nevertheless, there
are tendon-associated markers that may assist the establishment of tenogenic pro-
tocols and offer new perspectives for studying tendon biology.
The transcription factor scleraxis (Scx) is expressed from immature to fully
differentiated stages of tendon cells. Other factors, namely, Mowahk (Mwk), Egr1,
and Egr2 are detected at the stage of tenoblasts. Both tendon-progenitor cells and
tenoblasts also express collagen I, Tenascin (TNC), Thrombospondin (Thbs4), and
Tenomodulin (Tnmd). Mature tenocytes typically express Scx and Mwk as well as
Egr1 and Smad3. Developmental and in vitro studies have been pointing Scx and
Mwk as tendon-specific factors despite the fact they can be detected in other tissues.
The ECM matrix produced by tenocytes is rich in collagen I, III, V, and XIV;
Decorin; Fibromodulin; Lumican; and Tnmd.
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The tenocytes are organized in longitudinal rows between collagen fibers and
respond to mechanical forces. These cells establish communication with adjacent
cells usually through connexins 26, 32, and 43 in gap junctions. Tendon cell activity
declines with age leading to unbalanced processes thus contributing to tissue degen-
eration and to incremental severity of injuries.
More recently, stem progenitor cells (TSPCs) were identified in tendons shown to
possess regenerative capabilities (Salingcarnboriboon et al. 2003; Bi et al. 2007; de
Mos et al. 2007; Zhang and Wang 2010). TSPCs exhibit the typical surface antigens
of adult mesenchymal stem cells (MSCs), self-renewal, clonogenicity, and tri-line-
age differentiation, fitting the classical MSCs criteria, and highly express tendon-
specific factors, namely, Scx and Tnmd (Bi et al. 2007).
Paratenon, epitenon, and endotenon are the non-tenogenic components of ten-
dons. The paratenon allows tendon to move freely and continues to the fascia, while
epitenon is defined as a dense connective tissue sheath covering tendon. Both are
vascularized and enervated. Endotenon is formed by collagen fibers surrounding the
tertiary fascicles of the tendon. Not all tendons are sheathed by paratenon although
there is evidence of its involvement in tendon healing (Dyment et al. 2013; Muller
et al. 2018).
During the last decade, tremendous effort has been done pursuing the key features
of tendon niches to recapitulate tendon biology enabling the identification of specific
tissue requirements guiding the mechanisms underlying healing and regeneration
phenomena. Undoubtedly, the mechanical forces applied to tendons are critical for
the maintenance of the homeostasis in healthy tendons, and that misuse or overuse
can deregulate the physiological balance inflicting pathological alterations at a
biomolecular and cell levels, thus contributing to impaired healing and abnormal
tissue functionality. Understanding how mechanical forces regulate (stem) cell
behavior and matrix features may provide key insights on tendon biology and assist
the development of regenerative therapies (Vining and Mooney 2017).
This chapter overviews tendon engineering approaches to mimic tendon niches
envisioning sophisticated alternatives to stimulate tendon healing and regenerative
processes, anticipating functional contributions for improved tendon-oriented ther-
apies and treatments.
2 Tendon Injuries and Repair Mechanisms
Along with the socioeconomic burden, tendon pathologies are a significant cause for
disability for both working and ageing populations. The incidence of tendon injuries
is rising and becoming a paramount problem without effective therapeutics. Despite
tendons are designed to withstand mechanical forces, they are prone to lesions that
aggravate with the time, compromising articular performance and the quality of
movements and physical activities. Damage in the joint may eventually lead to
morbidity, pain, and osteoarthritis (Wang et al. 2012). Although genetic predisposi-
tion factors make individuals more or less susceptible to injury (Riley 2004; Rees
et al. 2006; Docheva et al. 2015), tendons become more prone to degeneration and to
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injuries with advanced stages of life. Moreover, aging and age-related pathogenesis
are also associated to impaired healing, presenting a huge opportunity to address the
unmet needs for new therapies and customized treatments for tendon diseases.
Excessive mechanical loading resulting from small repetitive strains may lead to
accumulation of tendon microinjuries (Soslowsky et al. 2000; Willett et al. 2007)
contributing for the progression of tendinopathic conditions. Tendinopathy typically
defines a non-rupture injury in the tendon or paratenon, which is exacerbated by
mechanical loading and typically accompanied by pain/swelling of injured tendon.
Pain and functional limitation are frequent symptoms conventionally treated with
nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and physical reha-
bilitation. However, the prolonged systemic action of these drugs has been reported
to cause significant long-term side effects as changes in blood pressure, myocardial
infarction and strokes, increased bleeding, osteoporosis, or peptic ulcers. The more
severe cases typically require surgical intervention, which rely on tissue replacement
with auto- or allografts (Rodrigues et al. 2013). However, these are often accompa-
nied with donor site morbidity, pain, inferior functionalities, and eventually graft
failure. The limited long-term success of surgical procedures compromises tendon
functionality impacting the quality of life of patients.
The healing capacity of tendons varies according to severity of injury and
anatomical location, and it is classically divided in three main stages. The first
stage is a short inflammatory phase that initiates after injury. The vascular perme-
ability increases as well as the influx of inflammatory cells (platelets, macrophages,
monocytes, and neutrophils) to the site of injury. These cells release chemotactic
agents responsible for the recruitment of blood vessels, fibroblasts, and intrinsic
tenocytes that together with inflammatory cells form a hematoma (Lin et al. 2004).
As part of the inflammatory response, macrophage phagocyte injured tissue frag-
ments and has an important role on tenocytes proliferation and angiogenesis (Woo et
al. 1999). The second stage is characterized by an abundant proliferation of
tenocytes at the site of injury with concomitant production of collagen. This phase
lasts from a few days to a couple of weeks. The remodeling phase is the third and
final stage and can last several months (Sharma and Maffulli 2005). The extracellular
matrix is reorganized with a gradual change in the direction of collagen fibers from
fibrous to scar-like tissue accompanied by a cellular decrease and reduction of
vascular vessels (Sharma and Maffulli 2006).
Tendon healing was traditionally described to be intrinsic or extrinsic in nature.
The intrinsic process was mediated by tenocytes from epitenon and endotenon, and
the repaired tissue evidenced higher mechanical properties and fewer complications.
Extrinsic healing was dependent on cell migration from adjacent tissues resulting in
scar tissue leading to adhesions formation (Sharma and Maffulli 2005; Zhao et al.
2015). Although the repair process depends on the anatomy and physiology of each
tendon, tendon healing is now described to occur from the interplay of local tendon
cells and external cells, including immune, vascular, synovial, and mesenchymal
stem cells.
Understanding and modulating the mechanisms underlying healing will allow
more effective treatments and rehabilitation. Moreover, as a key process in tendon
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tissues, insights tendon healing and the research of tendon mechanobiology will
likely contribute to advanced clinical solutions resourcing to tissue engineering and
regenerative medicine strategies.
3 Mechanoregulation Mechanisms
As mechanosensitive and mechanoresponsive tissue, the main function of tendon is
transmitting tensile loads that varies with the anatomical location and can reach to
several tens of megapascal (MPa). This incredible feature of tendons is extremely
dependent on its structure and cellular organization, and it is critical for the proper
function of joints (Killian et al. 2012; Lavagnino et al. 2015). The unique structure
and composition confer tendon a characteristic mechanical behavior which is clas-
sically described in a stress-strain curve (Fig. 1). The initial “toe” region represents
the flattening of crimp pattern when tendon is strained up to 2%. In the linear region,
tendon is stretched up to 4%, and collagen fibers lose the crimp pattern. Altogether,
these regions represent the physiological response of tendon. If tendon is stretched
more than 4%, a microscopic failure of collagen fibers occurs. However, when the
Fig. 1 Typical stress-strain curve of tendon tissues exposed to increasing mechanical loads
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forces applied are below this value, tendon remains in the elastic zone and can return
to its original shape when a load is removed. Macroscopic failure of collagen fibers is
observed in loads between 8 and 10%, while rupture of collagen fibers is verified
with mechanical loads higher than 10%.
Thus, the sensing of mechanical forces by the cells and further translation of the
cellular response to microenvironmental cues is of utmost importance in deciphering
precise mechanisms of action toward tenogenic recipes and opens avenues of
research seeking to develop efficient therapies.
Mechanotransduction is the ability of cells to respond to mechanical stimuli
through biochemical signals (Santos et al. 2015) being important to maintain
musculoskeletal tissue development, homeostasis, repair, and regeneration (Wang
2006). Cells are able to sense distinct mechanical stimulus within the matrix and to
respond accordingly and rapidly by adjusting physical ligands or rearranging its
cytoskeleton. These adjustments affect the perception of loading in the
mechanosensory elements of cells, present in the cellular membrane and nucleus.
Signaling cascades are the main routes of communication between the membrane
and intracellular regulatory targets. The two main signaling pathways identified as
being involved in tendon development are TGFβ-SMAD2/3 and FGF-ERK/MAPK
pathways (Havis et al. 2014a). FGF signaling from the myotome was firstly associ-
ated to induction of Scx-expressing tendon progenitors in adjacent somatic sub-
compartment of developing axial tendons in chick (Brent et al. 2003).
Interestingly, in pharmacologically immobilized chick embryos, both FGF and
TGF-β signaling cascades were downregulated, suggesting that FGF and TGF-β
ligands regulate tendon differentiation acting downstream to mechanical forces
present in developing embryo (Havis et al. 2016).
In mammalians, there are three isoforms of TGF-β, and all are involved in
tenogenic differentiation. Studies reported that in the presence of TGF-β1 the
expression of Scx and Mkx is highly upregulated (Farhat et al. 2012), and the
decline of mechanical properties was significantly hindered (Katsura et al. 2006).
The isoform TGF-β2 increased the expression of Col1a1 and Scx genes (Havis et al.
2014b; Liu et al. 2015), while TGF-β3 promoted tendon differentiation of equine
embryo-derived stem cells (Barsby and Guest 2013). Furthermore, TGF-β3 was
suggested to be an essential element of a recently proposed tenogenic differentiation
cocktail (Stanco et al. 2019).
Generally, in a signaling cascade, the ligand requires two types of serine/threo-
nine kinases receptors, a type I and a type II that form a receptor complex. Some
ligands require additional co-receptors for binding between the ligand and the
complex receptor. In the receptor complex, the cytoplasmic domain of the type II
receptor is active and phosphorylates the type I receptor on serines and threonines in
a highly conserved glycine- and serine-rich domain, neighboring the region that
crosses the membrane. The activated type I receptor supplies a ligand binding site for
the downstream substrates, the receptor-regulated SMADs (R-SMADs) that will
transduce the signal to the nucleus (Wrighton et al. 2009; Wakefield and Hill
2013). The TGF-βs, activins, and NODAL signal through SMAD2 and SMAD3
(Wakefield and Hill 2013; Zhang et al. 2018a). In humans, there are seven type I
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receptors known as activin receptor like-kinases (ALK) each being responsible to
regulate the phosphorylation of different R-SMADs. ALK1, ALK2, ALK3, and
ALK6 phosphorylate SMAD1, SMAD5, and SMAD8, while ALK4, ALK5, and
ALK7 phosphorylate SMAD2 and SMAD3 (Schmierer and Hill 2007).
Furthermore, the synergistic effect of mechanical stimulation and the activation of
TGF-β/SMAD2/3 cascade has an important role on the regulation of mechanical and
biochemical signaling pathways that regulate Scx expression (Maeda et al. 2011;
Goncalves et al. 2018b).
4 Tendon Tissue Engineering
4.1 Challenges of Cell-Based Approaches
Tendon tissue engineering has been challenged by a significant lack of understand-
ing in the identification and characterization of tendon niches. As functional living
entities, cells are of critical importance on the interplay of biological responses
leading to tissue repair and regeneration. Despite the growing knowledge, the precise
culture conditions and environment cues to stimulate tendon resident cells and guide
cell fate require further developments.
In 2007, Bi et al. reported a novel stem/progenitor cells (TSPCs) population
within the tendon fascicle (Bi et al. 2007). Despite the efforts, the origin of resident
tendon-progenitor/stem cells and the factors that influence their differentiation is still
poorly understood, compromising the design and development of novel repair and
regenerative strategies.
TSPC subsets have been identified in peritenon (Cadby et al. 2014; Mienaltowski
et al. 2014) holding unique signatures yet both capable of tenogenic differentiation
and forming collagen-rich structures (Cadby et al. 2014, Mienaltowski et al. 2014).
Mienaltowski MJ et al. reported that stem cells from tendon proper are more suited
for regeneration of tendon structure, while stem cells from peritendon secreted
tendon-promoting factors that bolster expression of tendon markers in tendon proper
stem cell and tenocytes (Mienaltowski et al. 2014). Cadby JA et al. observed that
cells from the peritenon migrated faster replicate more quickly holding higher
expression of progenitor cell markers (Cadby et al. 2014).
Within paratenon tissues, fibroblastic, vascular, synovial, neural, and fat cells may
be detected. TSPC subsets expressing vascular (Mienaltowski et al. 2014) markers
have also been described which emphases the intercellular role in homeostasis and in
the healing processes. In particular, the vicinity of vascular cell populations of
pericytes or perivascular cells has attracted a lot of attention in tendon biology not
only because perivascular niche may be source for epitenon-derived stem cells,
known to express vascular markers but the fact that extrinsic healing in tendons
rely on the migration of cells from surrounding tissues, including blood vessels.
These mechanisms are central to our understanding of the onset and development of
tissue pathologies and to guide cellular responses with precise regenerative action.
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The origin of stem cells populations relates to distinctive signature profiles yet
with complementary roles in tendon biology. Moreover, cell plasticity of tendon core
and peritendinous sources may provide particular contributions for tendon repair
mechanisms and for improved therapeutic solutions for tendon pathologies.
Despite the therapeutic promise of TSPCs, the limited number of local TSPC
populations, especially in adult and elder patients, and the invasiveness of the
harvesting procedures from a relatively hypocellular tissue can compromise their
availability and use in the clinical practice. Moreover, local cell sources require the
patient to wait for cell expansion procedures until a suffice number of cells is achieved
for implantation. Thus, alternative cell sources have been investigated for tissue
engineering and regenerative medicine strategies. Mesenchymal stem cells from
bone marrow and adipose tissue are heterogeneous sources described not to incite
immunologically adverse responses or to raise ethical constrains as pluripotent stem
cells (ESCs and iPSCs) and have been pursued for tenogenic phenotype with evidence
of improving tendon healing in in vivo models of tendon injuries (Gonçalves et al.
2013; Shen et al. 2018). Unlike TSPCs, bone marrow and adipose tissue-derived stem
cell sources are considerably available and have recognized potential to be used for the
regeneration of different types of tissues including tendons (Yin et al. 2016; Perucca
Orfei et al. 2019). Tendon-oriented strategies employing non-tenogenic MSCs cul-
tures typically rely on inductive factors to stimulate tenogenic cues such as TGF-β
(Gonçalves et al. 2013), GDF-5, and connective tissue growth factor (CTGF), despite
the fact that cocktails have not been fully established (Yin et al. 2016, Perucca Orfei et
al. 2019). Moreover, previous studies by our research group (Rada et al. 2011a, b,
2012; Mihaila et al. 2013, 2014, 2015; Goncalves et al. 2018a) and others (Miranville
et al. 2004; Sengenes et al. 2007) show that human adipose stem cells (hASCs) are
composed of subpopulations with distinct differentiation potential, which highlights
the differential role of subpopulations to lineage commitment and toward tissue-
oriented applications. ATenomodulin positive subpopulations demonstrated increased
tenogenic differentiation potential (Goncalves et al. 2018a) when compared to the
crude population and also when compared to SSEA-4+ hASCs subpopulation
(Gonçalves et al. 2019).
The control over stem cell fate, either from tendinous or non-tendinous tissues for
cell-based therapies or as part of a multiscale approach offers new possibilities into
improved healing and treatment intervention of tendon pathologies. However, find-
ing tendon-specific markers enabling standardization of protocols and proper char-
acterization of the cellular roles within tendon tissues are still unmet features to be
addressed in the following years.
4.2 Biomaterial Approaches for Tendon Tissue Engineering
Tendon TE strategies where the tenogenic niche is being mimicked are prone to
induce a more adequate response regarding cell phenotype and fate. Different studies
have emerged in this field in which several aspects of tendons’ ECM structure and
composition were recapitulated into mechanically competent constructs and cell
behavior assessed, aiming to induce endogenous tissue repair.
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4.2.1 Fibrous Scaffolds for Tendon Tissue Engineering
Two- and three-dimensional (2D and 3D) structures designed to resemble native
tendons have been developed over the years (Chainani et al. 2013). Attending to
their architecture, some authors developed systems mainly based on fibrous scaf-
folds where the fiber diameter, alignment, and overall stiffness were considered as
topographic beacons to guide cell fate. Others valued the mechanical demand these
tissues are subjected to and considered mechanical stimulation.
Strategies Involving Topographic Cues
Concerning 2D systems, these are mostly developed to evaluate how different
stimuli influence cell behavior, once they usually lack appropriate mechanical
properties for potential clinical application (Spanoudes et al. 2014, Santos et al.
2017). Fiber diameter and alignment have been proven to modulate cell’s behavior
conjointly. Systems with topographic cues in the nanoscale seem to be more
effective in allowing cell growth and synthesis of glycosaminoglycans (GAGs)
and collagen overtime, in either random 4 or aligned (Erisken et al. 2013a; Lee
et al. 2017) conformations. Micro-cues, on the other hand, have been shown to
suppress cell growth and collagen synthesis (Gilchrist et al. 2014; Lee et al. 2017).
Regarding cell morphology, both tendon cells (Erisken et al. 2013b; English et al.
2015) and MSCs (Bashur et al. 2009) present higher cell aspect ratio when exposed
to substrates with microfeatures compared to nanocues (Yu et al. 2013). Addition-
ally, anisotropic constructs are more prone to induce the tenocyte-like spindle-shape
morphology and alignment along nanofibers’ axis in the seeded cells, as opposed to
the arbitrarily oriented cell morphologies acquired in random substrates (Moffat
et al. 2009; Xie et al. 2010). Nonetheless, grooves’ depths as small as 40 nm did not
induce tenocyte alignment despite their parallel organization, suggesting that there is
a minimum size cells can perceive (English et al. 2015). Accordingly, Domingues
et al. used a solution of poly-E-caprolactone (PCL) and chitosan (CHT) reinforced
with rod-shape nanofillers, cellulose nanocrystals (CNCs), to produce random and
aligned meshes through electrospinning with increased mechanical properties.
Tenocytes seeded onto the anisotropic constructs maintained their elongated pheno-
type with aligned arrangement, as opposed to the cells on the random meshes
(Domingues et al. 2016).
Furthermore, the expression of tendon-related markers as Scx, Tnmd, ColI, andMkx
by stem cells is enhanced in aligned surfaces, indicating that tenogenesis is encouraged,
while in randomly oriented membranes, osteogenic genes are upregulated (Zhang et al.
2015). Schoenenberger et al. also correlated substrate alignment with ECM turnover,
demonstrating that tendon cells on PCL random nanomats are polygonal and show
decreased Mkx, ColI, and ColIII expression getting further from a tenogenic profile, as
well as decreased MMP1 suggesting less matrix remodeling, as opposed to aligned
constructs (Schoenenberger et al. 2018).
Submicron 2D systems typically display limited dimensions and pore size, do not
respond properly to the mechanical demand necessary to support tendon healing,
and are generally too weak to be surgically implanted (Barber et al. 2013; Hakimi
et al. 2015; Zheng et al. 2017). Thus, 3D systems that mechanically sustain tissue
Multiscale Multifactorial Approaches for Engineering Tendon Substitutes 9
regeneration and mimic tendon architecture have been considered (Santos et al.
2017). By stacking multiple electrospun PCL aligned membranes, clinically relevant
sized constructs can be generated, allowing hASCs infiltration, alignment, and
higher Tnmd and ColIII expression than random multilayered scaffolds. In addition,
the tensile mechanical properties are improved upon cell seeding for anisotropic
constructs (Orr et al. 2015).
Mimicking the native tendon highly anisotropic and hierarchic architecture has
been a research priority (Brennan et al. 2018). Textile techniques, as braiding,
twisting, and weaving, enable the construction of 3D tendon scaffolds of incremental
organization and mechanical performance, from threads or yarns (Freeman et al.
2007, Czaplewski et al. 2014, Santos et al. 2017). Electrochemically aligned colla-
gen (ELAC) threads have shown to induce tenogenic differentiation of human
MSCs, unlike random collagen threads, evidenced by the superior expression of
Scx, Tnmd, TNC, and ColIII, accompanied by enhanced ECM deposition and
alignment (Kishore et al. 2012). When assembled into yarns, these natural-based
woven textiles exhibited a significant increase in their mechanical properties,
reaching an average tensile Young’s modulus between 500 and 600 MPa and
ultimate tensile strength (UTS) of 60–70 MPa, within the range of the native tendon
(Younesi et al. 2014). Additionally, the yarns maintained their tenoinductive ability,
with MSCs showing an increased expression of Tnmd and ColI overtime, parallel to
the inhibition of osteogenic markers (Kishore et al. 2012).
Following the same principle, Laranjeira et al. recreated the nano-to-macro
hierarchical and anisotropic structure of the native tendon by assembling woven
scaffolds of continuous and aligned electrospun nanofibrous threads, made of PCL
and CHT mechanically reinforced with CNCs (Domingues et al. 2016). The weaved
structures exhibited the native tendon nonlinear mechanical behavior with evidenced
toe region. The woven scaffolds presented a Young’s modulus smaller than 200 MPa
and UTS of approximately 40 MPa, whereas the yarn 12 of 300–400 MPa and
60 MPa, respectively (Laranjeira et al. 2017). As outcome, these structures not only
avoided the tenogenic phenotypic drift of human tenocytes but also triggered the
tenogenic differentiation of hASCs without biochemical supplementation, increas-
ing the expression of tendon-related markers TNC and SCX.
Strategies Involving Mechanical Stimulation
Besides topographic cues, cells are sensitive to applied mechanical forces within the
physiological range, capable of modulating their lineage commitment and ECM
biosynthesis and degradation (Wang et al. 2013; Gonçalves et al. 2018). Tendons
high physical demand and mechanosensitive behavior led to the development of
bioreactors as exogenous sources of mechanical stimulation, to recapitulate the in
vivo microenvironment native cells are exposed to (Wang et al. 2013; Spanoudes
et al. 2014; Gonçalves et al. 2018).
Subramony et al. assessed the role of nanofiber alignment and mechanical
stimulation on MSCs differentiation, in the absence of biochemical supplementation,
using electrospun unaligned and aligned poly(lactide-co-glycolic acid) (PLGA)
nanofibrous membranes, placed on a bioreactor that applied uniaxial tensile strain.
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The authors stated that tenogenic differentiation was induced on aligned substrates
with load application, whereas loading nonaligned scaffolds or exposing cells just to
aligned substrates did not induce proper differentiation, reinforcing the importance
of mechanical stimulation (Subramony et al. 2013).
Nonetheless, the use of bioreactors faces some shortcomings, as the inability to
use upon implantation and the cell impairment that may result from their physical
presence in culture environments (Riehl et al. 2012). Therefore, scaffolds incorpo-
rating magnetic responsiveness, which can be remotely actuated by the application
of an external magnetic field, allowing cell guidance and stimulation following
implantation have been recently developed (Goncalves et al. 2016). Considering
this, Tomás et al. used the setup proposed in a previous study (Laranjeira et al. 2017)
to produce yarns of continuous and aligned electrospun threads of PCL and CNCs
coated with iron oxide magnetic nanoparticles (MNPs) (Fig. 2). Cell studies revealed
that hASCs express tendon-related genes both in static and dynamic conditions after
11 days of culture (Tomás et al. 2019), in agreement with previous studies
(Laranjeira et al. 2017; Almeida et al. 2019). Furthermore, mechanical stimulation
lead to marked upregulation of Scx and Tnmd at the gene and protein levels (Fig. 2)
and downregulation of Runx2, suggesting a synergistic effect of nanotopography
and mechanical actuation on the tenogenic commitment.
4.2.2 3D Printing for Tendon Tissue Engineering
Over the past decade, 3D printing has evolved from layer-by-layer deposition of
materials to fabricate 3D scaffolds to bioprinting, which allows patterning and
assembly of cells and materials with a defined 3D organization to produce
bioengineered structures serving in regenerative medicine, pharmacokinetics, and
basic cell biology studies. Although there are many promising examples of the
application of this technology in various tissue engineering and regenerative med-
icine strategies (Bracaglia et al. 2017; Lim et al. 2017; Derakhshanfar et al. 2018;
Moroni et al. 2018a, b), its use for the fabrication of tendon TE scaffolds is a field
under development, and very few studies have been published. One of the first works
in the field was developed by Merceron et al. to fabricate a muscle-tendon unit
construct (Merceron et al. 2015). The combination of polymeric materials to print the
structural component with cell-laden bioink to print the cellular component resulted
in customizable hybrid/multimaterial constructs with anisotropic patterns, mimick-
ing tendon and muscle characteristics. Thermoplastic polyurethane (PU) and C2C12
myoblasts were used for the muscle side and PCL and NIH/3 T3 fibroblasts for the
tendon side. These constructs showed over 80% cell viability 1 week after printing,
and the cell organization was consistent with the native tissue interface. In a more
recent study, 3D musculoskeletal-tendon-like tissues were printed alternating layers
of gelatin methacryloyl and cells (tenocytes and myoblasts) around and between
posts created in a culture well, envisioning a screening platform. The cells showed
high viability in culture and tissue differentiation markers (Laternser et al. 2018).
The development of a magnetic scaffold by 3D printing for tendon tissue appli-
cations was described by us (Goncalves et al. 2016), based on a polymeric blend of
starch and PCL (SPCL) incorporating magnetic nanoparticles. The purpose was to
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combine structural features of the 3D scaffold with mechanomagnetic actuation to
study the differentiation of hASCs to the tenogenic phenotype and assist tendon
regeneration. The anisotropic scaffolds promoted the tenogenic differentiation of
hASCs under magneto-stimulation with evidence of good biocompatibility and
integration in an ectopic rat model (Goncalves et al. 2016). In a different strategy,
anticipating patient-specific therapies, 3D printed scaffold sleeves made of PCL-
PLGA-β-TCP were developed considering the size and shape of the tendon and bone
tunnel. Then, these scaffolds were seeded with MSCs and tested in vivo for up to
12 weeks in an anterior cruciate ligament (ACL) reconstruction model in rabbits
(Park et al. 2018). The construct enhanced osteointegration between the tendon and
tunnel bone in the ACL reconstruction (Park et al. 2018).
4.3 Role of Biological Cues in Tendon Tissue Engineering
Strategies
Substrates providing instructive cues through cell-surface contact guidance have
been associated with biochemical signals to add functionality, creating microenvi-
ronments for cell differentiation that closely resemble native tissues (Santos et al.
2017). Several bioinductive elements have been investigated as intermediaries of cell
destiny, as media supplements or surface modifications (Spanoudes et al. 2014; Lin
et al. 2018).
4.3.1 Strategies Involving Medium Supplementation with Growth
Factors
Strategies based on growth factors and other small cell-signaling molecules have
emerged in the context of tendon tissue regeneration. These have been identified as
potent modulators of cell fate, acting on chemotaxis, proliferation, matrix synthesis,
and/or differentiation (Baldwin et al. 2018; Dalby et al. 2018).
TGF-β3 is a modulator of tenocyte function and tendon development, since its
signaling is known to induce the expression of Scx, a potent tenogenic marker
(Leung et al. 2013). When used as a medium supplement in combination with
aligned PCL/CHT meshes, TGF-β3 has a synergistic effect on the expression of
tenogenic markers by BM-MSCs, suggesting that its individual action cannot trigger
the lineage commitment as structural cues do, but helps in tenocyte maturation
(Leung et al. 2013). Therefore, this growth factor is often used as a component of
tenogenic differentiation medium (Yang et al. 2016; Rothrauff et al. 2017; Wu et al.
2017). Accordingly, Yang et al. studied the combined effect of native tendon-derived
ECM obtained from decellularized tissues with TGF-β3 on the tenogenic

Fig. 2 (continued) (blue) and actin filaments (red). Scale bar: 100 μm; and (c) normalized mean
fluorescence intensity quantification of SCX and TNMD. Adapted from Tomás et al. (2019) with
permission from the Royal Society of Chemistry
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commitment of hASCs. They observed that on tissue culture plastic, the dual action
of TGF-β3 and decellularized tendon ECM markedly enhanced the expression of
Scx and Tnc when compared to their individual effect. Furthermore, this same trend
was observed on PCL aligned scaffolds (Yang et al. 2017). Moreover, hASCs seeded
in decellularized tendon ECM-supplemented collagen gels showed upregulation of
tendon-related genes and downregulation of bone-related genes, in comparison to
pure collagen scaffolds (Yang et al. 2013).
A different approach was considered by Engebretson et al. that used tendon
lysates as a form of supplementation together with cyclic mechanical stimulation
of human umbilical vein scaffolds with seeded MSCs. The tendon lysates used in a
static system increased the expression of tendon-related genes more than in non-
supplemented conditions, while when associated with cyclic mechanical stimulation,
it resulted in tissue enhanced tensile strength and fibril alignment, as in the native
tissue (Engebretson et al. 2017).
Several studies have demonstrated the positive impact of bone morphogenetic
protein-12 (BMP-12) on the tenogenic differentiation of MSCs and tissue healing
(Shen et al. 2013; Dale et al. 2018). Aligned gelatin methacryloyl/alginate yarns
loaded with BM-MSCs were exposed to static mechanical stretching and BMP-12
supplementation both independently and simultaneously (Rinoldi et al. 2019). This
combination enhanced stem cells tenogenic commitment although it inhibited col-
lagen gene expression (Rinoldi et al. 2019).
4.3.2 Biofunctionalization of Scaffolds with Growth Factors
Growth factors may present a very quick inactivation and short half-life when used
as medium supplements (Sahoo et al. 2010; Font Tellado et al. 2018). Therefore,
systems in which these therapeutic agents are incorporated for in situ action and
gradual delivery while ensuring their biological activity and stability hold numerous
advantages.
Knitted silk scaffolds coated with (FGF-2)-releasing ultrafine PLGA promoted
superior MSCs viability and proliferation although its role on tenogenesis was not
fully assessed (Sahoo et al. 2010). Likewise, tenocytes cultured on braided PCL/
collagen-FGF-2 scaffolds exhibited enhanced proliferation and expression of COLI,
COLIII, and TNC, and scaffolds subjected to dynamic stimulation and further
implanted in vivo enabled the deposition of aligned collagen after 12 weeks
(Jayasree et al. 2019).
The conjugation of connective tissue growth factor (CTGF) in hierarchically
electrospun scaffolds encouraged the proliferation of MSCs and the deposition of
COLI and III in vitro and in vivo; however stem cell differentiation was not
completely evaluated (Pauly et al. 2017). Even though CTGF has been positively
correlated with tendon regeneration, further studies should be conducted to better
understand its influence on tenogenic commitment (Lee et al. 2015; Shen et al. 2018).
A PDGF delivery system was developed using PLGA-monomethoxy-poly(eth-
ylene glycol) (PLGA-m-PEG) nanoparticles. These were then associated with col-
lagen to form aligned fibers through an electrochemical process. The alignment of
the collagen fibrils resulted in increased Tnmd gene expression by hASCs, with the
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controlled release of PDGF boosting this effect and leading to higher Scx expression,
in comparison with randomly oriented fibers (Cheng et al. 2014). Accordingly,
hASCs seeded on porous membranes with reverse gradients of PDGF-BB and
BMP-2 exhibited a tenogenesis-like behavior in the sections with higher PDGF-
BB and lower BMP-2 content, correspondent to the immunohistochemical observa-
tion of higher TNMD and lower bone sialoprotein expression, while osteogenesis
was promoted on the inverse situation (Min et al. 2014). More recently, PDGF was
immobilized on the surface of electrospun aligned structures of poly(l-lactic acid)
(PLLA) through a polydopamine (PDA) coating, forming a gradient of concentra-
tions. hASCs adhered and spread similarly along the gradient, proliferating better
than in the random scaffolds. Regarding the tenogenic differentiation, these cells had
the highest protein expression of SCX and TNMD in the sections with highest
amount of surface-bound PGDF, gradually decreasing with lower PDGF content
(Madhurakkat Perikamana et al. 2018).Both strategies are particularly interesting for
tendon to bone repair.
Silk fibroin scaffolds with isotropic (bone-like) and anisotropic (tendon-like)
sections were functionalized with heparin to immobilize TGF-β2 and growth differ-
entiation factor-5 (GDF-5). In the aligned segment, the presence of TGF-β2 allowed
the highest deposition of COLI and slightly increased ColI, Mkx, and Tnc expres-
sions, while in the isotropic region, the expression of the chondrogenic markers
Sox9, ColII, and aggrecan was upregulated in the simultaneous presence of TGF-β2
and GDF-5, therefore unveiling new possibilities for enthesis-targeting strategies
(Font Tellado et al. 2018).
Considering the reduced expression of histone deacetylases (HDACs) in native
tendon stem/progenitor cells, Zhang et al. tried to enhance their tenogenesis on
PLLA/poly(ethylene oxide) (PEO) aligned scaffolds using an HDAC inhibitor,
trichostatin A. This small molecule incorporated on the aligned PLLA fibers led to
increased mRNA expression of Scx and Mkx by TSPCs and superior SCX, COLI,
COLV, and TNMD protein expression. Random fibers, on the other hand, proved to
be the less efficient on TSPC tenoinduction (Zhang et al. 2018c).
4.3.3 Biofunctionalization of Scaffolds with ECM Components
Tendons are characterized by a scarce cell population within a very dense ECM
composed of several macromolecules, each playing a distinct role on the mechanical
function and biochemical signaling of the tissue (Yang et al. 2013). Hence, scaffolds’
biofunctionality in terms of cell adhesion and stem cell tenogenic commitment might
be enhanced with surface coatings of ECM components, to resemble the native
musculoskeletal tissue (Lin et al. 2018; Jenkins and Little 2019).
Collagen, the main component of tendon’s ECM, has been shown to improve the
adhesion and growth of tenocytes, when used either as a bulk material (Theisen et al.
2010) or as a coating (Qin et al. 2005; Czaplewski et al. 2014). Tong et al. replicated
native tendon’s microenvironment, namely, surface topography and elasticity, using
bio-imprinted substrates of polydimethylsiloxane (PDMS). When the surface chem-
istry was modified using a collagen type I coating, MSCs showed increased TNMD
expression without using exogenous growth factors (Tong et al. 2012). Additional
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tendon-related markers needed to be evaluated to better understand the impact on
cell differentiation.
Fibronectin, another well-defined cell adhesion enhancer, has been used along
with collagen in a strategy targeting to the bone-to-tendon transition (Sharma and
Snedeker 2010; Lin et al. 2018). Sharma et al. evaluated the influence of both
biochemical and biomechanical gradients on bone marrow stromal cells differenti-
ation along osteogenic and tenogenic lineages. For that, hydrogels of varying
stiffness at a cell length-scale (within the kPa range) were functionalized with
collagen and fibronectin. Osteoblast differentiation was observed on the stiffer
(80 kPa) and fibronectin-coated substrates. Tenogenic markers, on the other hand,
were upregulated on collagen-coated substrates with a stiffness of 40 kPa (Sharma
and Snedeker 2010). In general, softer substrates are more prone to induce tenogenic
differentiation, while rigid surfaces induce the expression of chondrogenesis and
osteogenic genes (Engler et al. 2006; Zhang et al. 2018b).
Elastin is another tendon ECM fibrous protein, responsible for tissue reversible
recoil (Miranda-Nieves and Chaikof 2017; Jenkins and Little 2019). In a recent
work, the surface of PCL/CHT/CNCs yarns (Laranjeira et al. 2017) was
functionalized with tropoelastin (TROPO), the soluble precursor of elastin, through
PDA linking (Fig. 3), thereby tuning its elasticity and composition to mimic the
tendon native ECM (Almeida et al. 2019). Upon the decrease of surface stiffness
with the incorporation of PDA and TROPO, hASCs acquired faster the tenocyte-like
spindle-shape morphology and exhibited a sustained expression of Scx and Tnmd, up
to 21 days of culture. Even though all conditions led to the production of a tendon-
Fig. 3 (a) Schematic representation of the general strategy to immobilize TROPO on the surfaces
of yarns mimicking tendon collagen fascicles via PDA linking; and (b) confocal images of
immunolabeled samples against elastin (ELN – green) expressed by hASCs after 21 days of culture,
with stained nuclei (blue) and cytoskeletons (red). Scale bar for low and high magnifications: 100
and 50 μm, respectively. Reprinted (adapted) with permission fromAlmeida et al. (2019). Copyright
(2019) American Chemical Society
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like ECM, immunocytochemistry data shows that only in the presence of TROPO,
cells synthesized and deposited elastin creating a more mimetic matrix in compar-
ison with the other conditions (Fig. 3) (Almeida et al. 2019).
5 Conclusions
The cellular interactions and mechanisms underlying tendon tissues remain to be
fully elucidated, challenging strategies that would greatly benefit from the knowl-
edge of tenogenic benchmarks as specific biomarkers for tendon cell maturation,
appropriate stimuli conditions, and/or the factors leading to impaired tendon healing.
As a mechanoresponsive tissue, mechanical cues are key features for tendon homeo-
stasis and function. Several works have been emphasizing scaffolds’ topographic
cues and mechanical stimulation as powerful modulators of cell fate. All the
proposed strategies provide insightful information about the interactions between
cells and their substrates. However, these systems are often considered overly
simplistic as do not consider the biological signaling present in the in vivo niche.
Therefore, associating bioactive prompts to scaffolds is an increasingly trend in
tendon tissue engineering.
In the years to come, cellular interactions with the different stimuli should be
deeply investigated, and the spatiotemporal dynamics of cellular differentiation and
tissue maturation assessed in the presence of artificial tenogenic stimuli to determine
preferential rankings among conditioning factors. Another aspect to be considered in
future strategies is the anatomical location of tendon tissues. Distinct locations
within the body relate to dissimilar microenvironments, which likely influence
different responses to stimuli and to repair mechanisms.
In summary, multiple aspects of tendon physiology in combinatorial strategies
have been explored in the context of tendon TERM. The combination of both
biomechanical and biochemical cues has been shown to produce biomimetic tendon
scaffolds from nano- to macro-scales, although the optimal strategy to achieve
tendon regeneration continues an unmet research and clinical need. The recreation
of tendon niche complexity demands for the assessment of suitable cellular and
environmental conditions and for the development of more sophisticated tendon
substitutes with improved tenogenic functions for therapeutic application in tendon
pathologies.
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